iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 2B70.DE · ETF Open iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) in new tab
Weights
Sector Weights
Country Weights
United States
United Kingdom
Netherlands
Ireland
Switzerland
Denmark
France
Canada
Germany
Luxembourg
China
Spain
Australia
Israel
Belgium
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) Analysis (2B70.DE)
Investment Objective: iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is an investment vehicle . It is currently trading at 8.80 EUR.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%)
and markets in
United States (88%),
United Kingdom (2%),
Netherlands (2%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
Investor FAQ
Does iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) pay a dividend?
No, it does not currently pay a dividend.
What asset class is iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)?
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) is classified as a ETF. You can compare it against 5 other assets in the "Related Symbols" list on this page.
Fund Strategy
No detailed summary available for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc).
Community Discussion